KO | Aktier | 636,537 mia. | — | KO KoAct | 0 | Sundhedsvæsen | | 3.8.2023 | 23.336,27 | 9,54 | 37,04 |
KO | Aktier | 293,556 mia. | — | KO KODEX | 0,45 | Sundhedsvæsen | FnGuide Bio Index - Benchmark TR Gross | 13.5.2016 | 13.140,85 | 7,35 | 37,93 |
TE | Aktier | 290,568 mia. | — | TE Tiger ETF | 0,40 | Sundhedsvæsen | KRX Bio K-New Deal Index - KRW - Benchmark TR Gross | 6.10.2020 | 8.301,29 | 5,81 | 62,59 |
TE | Aktier | 202,047 mia. | — | TE Tiger ETF | 0,40 | Sundhedsvæsen | KRX Healthcare - KRW | 15.7.2011 | 50.817,26 | 5,63 | 47,81 |
TE | Aktier | 104,964 mia. | — | TE Tiger ETF | 0,30 | Sundhedsvæsen | NASDAQ / Biotechnology | 26.8.2014 | 31.350,97 | 5,08 | 22,19 |
KO | Aktier | 96,449 mia. | — | KO KODEX | 0,09 | Sundhedsvæsen | KRX Healthcare - KRW | 28.3.2017 | 22.975,75 | 5,63 | 47,83 |
TE | Aktier | 95,142 mia. | — | TE Tiger ETF | 0,40 | Sundhedsvæsen | KOSDAQ 150 Biotech Index - KRW - Benchmark TR Gross | 14.12.2016 | 20.325,91 | 12,17 | 59,10 |
KR | Aktier | 72,546 mia. | — | KR KB RISE | 0 | Sundhedsvæsen | KRX Bio Top 10 Index - KRW - Benchmark TR Gross | 24.12.2024 | 17.668,54 | 9,56 | 68,04 |
KO | Aktier | 63,182 mia. | — | KO KODEX | 0,25 | Sundhedsvæsen | S&P Health Care Select Sector | 21.3.2023 | 13.695,71 | 5,11 | 23,89 |
TE | Aktier | 62,455 mia. | — | TE Tiger ETF | 0,49 | Sundhedsvæsen | Solactive China Biotech Index | 3.12.2020 | 8.266,30 | 3,99 | 35,92 |
TE | Aktier | 47,316 mia. | — | TE Tiger ETF | 0,45 | Sundhedsvæsen | Indxx Global Obesity Treatment Top 2 Plus index - KRW - Benchmark Price Return | 29.2.2024 | 10.235,42 | 9,43 | 20,11 |
KO | Aktier | 44,244 mia. | — | KO KODEX | 0,45 | Sundhedsvæsen | iSelect Global Obesity Treatment TOP2 Plus Index - KRW - Benchmark TR Net | 14.2.2024 | 10.770,47 | 5,71 | 14,97 |
SP | Aktier | 40,177 mia. | 12,758 mio. | SP SPDR | 0,08 | Sundhedsvæsen | S&P Health Care Select Sector | 16.12.1998 | 152,89 | 5,20 | 24,21 |
TE | Aktier | 32,539 mia. | — | TE Tiger ETF | 0,40 | Sundhedsvæsen | KOSPI 200 Health Care Index - KRW | 23.9.2015 | 22.065,13 | 3,72 | 44,56 |
TE | Aktier | 31,358 mia. | — | TE Tiger ETF | 0 | Sundhedsvæsen | S&P Global 1200 Health Care Custom Index - krw - Benchmark TR Gross | 29.6.2016 | 25.908,41 | 0 | 0 |
HW | Aktier | 28,041 mia. | — | HW Hwabao | 0,60 | Sundhedsvæsen | CSI Medical Index Yield - Benchmark TR Gross | 20.5.2019 | 0,34 | 3,08 | 30,88 |
KO | Aktier | 20,124 mia. | — | KO KODEX | 0,25 | Sundhedsvæsen | S&P Biotechnology Select Industry | 31.10.2013 | 40.159,61 | 0 | 0 |
NH | Aktier | 17,742 mia. | — | NH NH-Amundi | 0 | Sundhedsvæsen | | 26.11.2024 | 16.568,54 | 6,27 | 44,18 |
EF | Aktier | 17,641 mia. | — | EF E Fund | 0 | Sundhedsvæsen | CSI 300 Medical and Health Index - CNY - Benchmark TR Gross | 9.1.2021 | 0,37 | 3,40 | 26,67 |
VA | Aktier | 16,921 mia. | 259.153,6 | VA Vanguard | 0,09 | Sundhedsvæsen | MSCI US IMI 25/50 Health Care | 26.1.2004 | 282,72 | 5,01 | 23,10 |
KO | Aktier | 14,362 mia. | — | KO KoAct | 0,50 | Sundhedsvæsen | | 11.11.2025 | 10.280,58 | 5,63 | 23,60 |
KR | Aktier | 11,679 mia. | — | KR KB RISE | 0 | Sundhedsvæsen | FnGuide HealthCare Index - KRW - Benchmark TR Net | 23.9.2016 | 18.021,90 | 5,61 | 41,78 |
KI | Aktier | 9,094 mia. | — | KI Kiwoom | 0,49 | Sundhedsvæsen | FnGuide Medical AI Index - KRW - Benchmark TR Gross | 28.5.2024 | 14.329,37 | 0 | 0 |
AC | Aktier | 9,093 mia. | — | AC ACE | 0,30 | Sundhedsvæsen | Solactive Global Big Pharma Index - Benchmark Price Return | 19.11.2024 | 12.922,48 | 7,56 | 22,90 |
KO | Aktier | 8,874 mia. | — | KO KODEX | 0 | Sundhedsvæsen | | 27.1.2026 | 9.342,76 | 3,99 | 29,08 |
AC | Aktier | 8,594 mia. | — | AC ACE | 0,45 | Sundhedsvæsen | Solactive Eli Lilly Value Chain Index - Benchmark Price Return | 19.11.2024 | 12.103,33 | 3,78 | 24,48 |
IS | Aktier | 8,399 mia. | 1,75 mio. | IS iShares | 0,44 | Sundhedsvæsen | NYSE Biotechnology (TR) | 5.2.2001 | 171,02 | 5,24 | 22,86 |
SP | Aktier | 8,17 mia. | 8,524 mio. | SP SPDR | 0,35 | Sundhedsvæsen | S&P Biotechnology Select Industry | 31.1.2006 | 126,42 | 5,04 | 0 |
TE | Aktier | 6,472 mia. | — | TE Tiger ETF | 0,50 | Sundhedsvæsen | FnGuide Medical Device Index - KRX - Benchmark TR Net | 7.11.2018 | 18.621,67 | 2,99 | 23,45 |
BO | Aktier | 6,342 mia. | — | BO Bosera | 0,65 | Sundhedsvæsen | Hang Seng Healthcare Index - CNY - Benchmark TR Gross | 18.3.2021 | 0,58 | 2,75 | 12,80 |
MA | Aktier | 6,177 mia. | — | MA Maxwealth | 0,60 | Sundhedsvæsen | CSI All-Medical Device Index - CNY - Benchmark TR Gross | 22.4.2021 | 0,50 | 2,64 | 31,06 |
CH | Aktier | 6,126 mia. | — | CH ChinaAMC | 0,65 | Sundhedsvæsen | Hang Seng Biotech Index - HKD - Benchmark TR Net | 29.9.2021 | 0,75 | 3,00 | 21,32 |
KI | Aktier | 5,787 mia. | — | KI Kiwoom | 0,49 | Sundhedsvæsen | Solactive Blockbuster Biotech Drugs Index - CNY - Benchmark TR Net | 28.5.2024 | 11.508,44 | 4,44 | 18,33 |
KO | Aktier | 5,68 mia. | — | KO KoAct | 0,50 | Sundhedsvæsen | | 3.9.2024 | 12.617,46 | 4,13 | 18,53 |
NI | Aktier | 5,441 mia. | — | NI Nippon | 0,19 | Sundhedsvæsen | Nifty Pharma Index - INR - Benchmark TR Gross | 2.7.2021 | 17,49 | 4,59 | 31,47 |
NF | Aktier | 5,278 mia. | — | NF NEXT FUNDS | 0,32 | Sundhedsvæsen | | 21.3.2008 | 32.216,48 | 1,89 | 20,85 |
KR | Aktier | 5,247 mia. | — | KR KB RISE | 0,35 | Sundhedsvæsen | KEDI Global Obesity Care Industry Top2+ Index - KRW - Benchmark TR Net | 27.2.2024 | 9.608,44 | 8,05 | 19,51 |
TE | Aktier | 4,915 mia. | — | TE Tiger ETF | 0,40 | Sundhedsvæsen | TOPIX-17 PHARMACEUTICAL - JPY | 29.6.2016 | 12.065,00 | 0 | 0 |
IC | Aktier | 4,753 mia. | — | IC ICBC | 0 | Sundhedsvæsen | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 26.3.2025 | 1,25 | 0 | 0 |
IN | Aktier | 4,108 mia. | — | IN Invesco | 0 | Sundhedsvæsen | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 16.10.2024 | 1,52 | 3,45 | 24,62 |
EF | Aktier | 4,018 mia. | — | EF E Fund | 0 | Sundhedsvæsen | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 18.3.2025 | 1,18 | 0 | 0 |
IS | Aktier | 3,806 mia. | 293.937,6 | IS iShares | 0,40 | Sundhedsvæsen | S&P Global 1200 / Health Care -SEC | 13.11.2001 | 96,46 | 4,53 | 22,88 |
GU | Aktier | 3,775 mia. | — | GU Guotai | 0,60 | Sundhedsvæsen | CSI Biomedical Index - CNY - Benchmark TR Gross | 18.4.2019 | 0,96 | 0 | 0 |
XT | Aktier | 3,422 mia. | — | XT Xtrackers | 0,25 | Sundhedsvæsen | MSCI World Index / Health Care -SEC | 22.11.2010 | 57,66 | 4,75 | 23,33 |
IS | Aktier | 3,378 mia. | 1,913 mio. | IS iShares | 0,38 | Sundhedsvæsen | DJ US Select / Medical Equipment | 1.5.2006 | 56,27 | 4,15 | 32,44 |
IS | Aktier | 3,022 mia. | 719.638,1 | IS iShares | 0,38 | Sundhedsvæsen | Russell 1000 Health Care RIC 22.5/45 Capped Index | 12.6.2000 | 63,89 | 5,15 | 24,12 |
FU | Aktier | 2,987 mia. | — | FU Fullgoal | 0,60 | Sundhedsvæsen | Hang Seng Hong Kong Stock Connect Healthcare Index - CNY - Chinese Renminbi - Benchmark TR Gross | 14.6.2023 | 1,30 | 0 | 0 |
FI | Aktier | 2,905 mia. | 189.904,2 | FI Fidelity | 0,08 | Sundhedsvæsen | MSCI US IMI 25/50 Health Care | 21.10.2013 | 73,00 | 5,09 | 24,20 |
NH | Aktier | 2,735 mia. | — | NH NH-Amundi | 0,45 | Sundhedsvæsen | iSelect K-MediTech Index - KRW - Benchmark Price Return | 21.12.2023 | 9.115,65 | 3,43 | 26,31 |
IS | Aktier | 2,661 mia. | — | IS iShares | 0,15 | Sundhedsvæsen | S&P 500 CAPPED 35/20 HEALTH CARE NTR | 20.11.2015 | 12,24 | 5,25 | 24,46 |
GU | Aktier | 2,305 mia. | — | GU Guotai | 0,60 | Sundhedsvæsen | CSI Medical Index Yield - Benchmark TR Gross | 24.12.2020 | 0,42 | 3,08 | 30,90 |
FT | Aktier | 2,287 mia. | 140.966,8 | FT First Trust | 0,54 | Sundhedsvæsen | NYSE Arca Biotechnology Index | 19.6.2006 | 199,34 | 3,40 | 22,79 |
HW | Aktier | 2,266 mia. | — | HW Hwabao | 0 | Sundhedsvæsen | Hang Seng SCHK Innovative Drug Select Index - HKD - Benchmark TR Gross | — | 4,71 mia. | 0 | 0 |
CH | Aktier | 2,16 mia. | — | CH ChinaAMC | 0,75 | Sundhedsvæsen | Hang Seng Biotech Index - HKD - Benchmark TR Net | 18.3.2021 | 14,37 | 3,50 | 28,15 |
CH | Aktier | 2,132 mia. | — | CH ChinaAMC | 0,75 | Sundhedsvæsen | Hang Seng Biotech Index - HKD - Benchmark TR Net | 18.3.2021 | 14,09 | 3,50 | 28,15 |
PA | Aktier | 1,862 mia. | — | PA Ping An | 0,60 | Sundhedsvæsen | CSI Pharmaceutical and Medical Device Innovation Index - CNY - Benchmark TR Gross | 9.6.2021 | 0,36 | 4,13 | 25,07 |
HE | Aktier | 1,626 mia. | — | HE Harvest ETFs | 1,06 | Sundhedsvæsen | | 19.11.2014 | 7,32 | 4,88 | 21,55 |
IS | Aktier | 1,508 mia. | — | IS iShares | 0,18 | Sundhedsvæsen | MSCI Europe Health Care 20/35 Capped Index - EUR | 17.11.2020 | 7,16 | 4,09 | 21,37 |
AM | Aktier | 1,49 mia. | — | AM Amundi | 0,50 | Sundhedsvæsen | MSCI World IMI Virology Select Index - KRW - Benchmark TR Net | 8.6.2022 | 9.937,75 | 2,82 | 14,76 |
EF | Aktier | 1,479 mia. | — | EF E Fund | 0,20 | Sundhedsvæsen | Yield of China Securities Hong Kong Stock Connect Medical and Health Composite Index - CNY - Benchmark TR Net | 19.1.2022 | 1,02 | 2,50 | 20,25 |
CA | Aktier | 1,44 mia. | — | CA Cathay | 1,05 | Sundhedsvæsen | Solactive Global Genomics Immunology and Medical Revolution Index - Benchmark TR Net | 22.11.2021 | 8,03 | 3,49 | 18,53 |
EF | Aktier | 1,403 mia. | — | EF E Fund | 0,20 | Sundhedsvæsen | CSI Biotechnology Theme Index - CNY - Benchmark TR Gross | 14.1.2021 | 0,48 | 2,80 | 29,20 |
EF | Aktier | 1,393 mia. | — | EF E Fund | 0,20 | Sundhedsvæsen | China Securities Medical Index - CNY - Benchmark TR Gross | 8.7.2021 | 0,40 | 4,40 | 29,55 |
IS | Aktier | 1,337 mia. | — | IS iShares | 0,46 | Sundhedsvæsen | S&P Global 1200 Healthcare Sector Index - AUD | 13.11.2001 | 134,80 | 0 | 0 |
GU | Aktier | 1,333 mia. | — | GU Guotai | 0,60 | Sundhedsvæsen | SSE STAR Market Innovative Drug Index - CNY - Benchmark TR Gross | 1.8.2025 | 0,84 | 0 | 0 |
VA | Aktier | 1,293 mia. | 407.269,5 | VA VanEck | 0,36 | Sundhedsvæsen | MVIS US Listed Pharmaceutical 25 | 20.12.2011 | 106,05 | 5,28 | 20,03 |
EF | Aktier | 1,216 mia. | — | EF E Fund | 0,20 | Sundhedsvæsen | CSI Innovative Drug Industry Index - CNY - Benchmark TR Gross | 3.2.2021 | 0,64 | 3,14 | 28,62 |
XT | Aktier | 1,157 mia. | — | XT Xtrackers | 0,12 | Sundhedsvæsen | MSCI USA / Health Care -SEC | 12.9.2017 | 61,33 | 5,43 | 24,63 |
XT | Aktier | 1,157 mia. | — | XT Xtrackers | 0,12 | Sundhedsvæsen | MSCI USA / Health Care -SEC | 12.9.2017 | 61,33 | 5,43 | 24,63 |
IS | Aktier | 1,036 mia. | — | IS iShares | 0,40 | Sundhedsvæsen | STOXX Global Breakthrough Healthcare (USD)(NR) | 8.9.2016 | 8,83 | 4,07 | 22,24 |
HA | Aktier | 1,035 mia. | — | HA Harvest | 0,60 | Sundhedsvæsen | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 30.7.2025 | 0,82 | 0 | 0 |
IS | Aktier | 1,029 mia. | — | IS iShares | 0,40 | Sundhedsvæsen | STOXX Global Breakthrough Healthcare (USD)(NR) | 8.9.2016 | 8,61 | 4,07 | 22,24 |
IS | Aktier | 1,019 mia. | 99.172,98 | IS iShares | 0,38 | Sundhedsvæsen | DJ US Select / Pharmaceutical | 1.5.2006 | 88,42 | 4,82 | 21,97 |
GX | Aktier | 945,537 mio. | — | GX Global X | 0,59 | Sundhedsvæsen | FactSet Japan Bio & Med Technologies Index - JPY - Benchmark TR Net | 21.6.2021 | 1.670,09 | 2,01 | 19,55 |
IS | Aktier | 916,313 mio. | — | IS iShares | 0,35 | Sundhedsvæsen | NASDAQ / Biotechnology | 19.10.2017 | 8,60 | 0 | 0 |
FT | Aktier | 875,51 mio. | 30.618,23 | FT First Trust | 0,61 | Sundhedsvæsen | StrataQuant Health Care Index | 8.5.2007 | 110,31 | 3,10 | 17,93 |
AM | Aktier | 865,766 mio. | — | AM Amundi | 0,30 | Sundhedsvæsen | STOXX Europe 600 / Health Care (Capped) - SS | 17.1.2019 | 151,73 | 3,03 | 20,62 |
AM | Aktier | 865,766 mio. | — | AM Amundi | 0,30 | Sundhedsvæsen | STOXX Europe 600 / Health Care (Capped) - SS | 17.1.2019 | 151,73 | 3,03 | 20,62 |
CS | Aktier | 850,434 mio. | — | CS CSOP | 1,50 | Sundhedsvæsen | Hang Seng Biotech Index - HKD - Benchmark TR Net | 21.7.2021 | 3,42 | 3,27 | 26,39 |
WA | Aktier | 775,039 mio. | — | WA Wanjia | 0 | Sundhedsvæsen | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 13.9.2024 | 1,47 | 3,45 | 24,62 |
AM | Aktier | 755,907 mio. | — | AM Amundi | 0,30 | Sundhedsvæsen | MSCI World Index / Health Care -SEC | 19.8.2010 | 483,47 | 7,68 | 29,88 |
IN | Aktier | 730,129 mio. | 94.989,37 | IN Invesco | 0,40 | Sundhedsvæsen | S&P 500 Equal Weighted / Health Care -SEC | 1.11.2006 | 31,35 | 3,30 | 21,11 |
IS | Aktier | 720,251 mio. | — | IS iShares | 0,46 | Sundhedsvæsen | STOXX Europe 600 / Health Care (Capped) - SS | 25.4.2001 | 114,02 | 3,80 | 20,28 |
CA | Aktier | 719,261 mio. | — | CA Cathay | 0,41 | Sundhedsvæsen | Bloomberg Barclays 15+ Year Healthcare Select Index - Benchmark TR Net | 23.4.2019 | 29,95 | 0 | 0 |
PB | Aktier | 718,658 mio. | 83.337,9 | PB Portfolio Building Block | 0,13 | Sundhedsvæsen | BITA Global Pharma and Biotech Select Index - Benchmark TR Net | 24.11.2025 | 25,97 | 5,48 | 21,33 |
IS | Aktier | 699,206 mio. | 278.6 | IS iShares | 0,38 | Sundhedsvæsen | DJ US Select / Health Care Providers | 1.5.2006 | 44,14 | 2,29 | 17,03 |
SP | Aktier | 634,15 mio. | — | SP SPDR | 0,30 | Sundhedsvæsen | MSCI World Health Care 35/20 Capped Index - Benchmark TR Net | 29.4.2016 | 66,56 | 5,08 | 25,68 |
GX | Aktier | 634,125 mio. | — | GX Global X | 0,68 | Sundhedsvæsen | Solactive China Biotech Index | 25.7.2019 | 68,10 | 4,17 | 39,20 |
GX | Aktier | 626,51 mio. | — | GX Global X | 0,68 | Sundhedsvæsen | Solactive China Biotech Index | 25.7.2019 | 66,81 | 4,17 | 39,20 |
CS | Aktier | 604,631 mio. | — | CS China Southern | 0,65 | Sundhedsvæsen | Hang Seng Biotech Index - HKD - Benchmark TR Gross | 17.6.2022 | 1,08 | 2,98 | 21,35 |
IS | Aktier | 602,289 mio. | — | IS iShares | 0,18 | Sundhedsvæsen | MSCI World Health Care ESG Reduced Carbon Select 20 35 Capped Index - Benchmark TR Net | 17.10.2019 | 7,64 | 4,16 | 22,04 |
SP | Aktier | 591,965 mio. | — | SP SPDR | 0,18 | Sundhedsvæsen | MSCI Europe Health Care Index - EUR | 5.12.2014 | 227,17 | 4,01 | 20,91 |
SP | Aktier | 572,362 mio. | — | SP SPDR | 0,15 | Sundhedsvæsen | S&P Health Care Select Sector Daily Capped 25/20 Index | 7.7.2015 | 47,21 | 5,20 | 24,21 |
IS | Aktier | 539,741 mio. | — | IS iShares | 0,66 | Sundhedsvæsen | S&P Global 1200 Health Care Hedged to CAD Index - CAD | 12.4.2011 | 69,50 | 0 | 0 |
CH | Aktier | 529,292 mio. | — | CH ChinaAMC | 0,60 | Sundhedsvæsen | CSI All-Medical Device Index - CNY - Benchmark TR Gross | 23.11.2023 | 0,87 | 2,64 | 31,04 |
FU | Aktier | 527,046 mio. | — | FU Fullgoal | 0,60 | Sundhedsvæsen | CSI Pharmaceutical 50 Index - CNY - Benchmark TR Gross | 16.3.2020 | 0,92 | 0 | 0 |
DI | Aktier | 526,958 mio. | 580.253,1 | DI Direxion | 0,96 | Sundhedsvæsen | S&P Biotechnology Select Industry | 28.5.2015 | 167,17 | 0 | 0 |
GU | Aktier | 479,196 mio. | — | GU Guotai | 0,60 | Sundhedsvæsen | CSI Shanghai-Hong Kong-Shenzhen Innovative Pharmaceutical Industry Index - CNY - Benchmark TR Gross | 8.9.2021 | 0,69 | 3,53 | 27,58 |
IN | Aktier | 430,562 mio. | — | IN Invesco | 0,40 | Sundhedsvæsen | NASDAQ / Biotechnology | 6.11.2014 | 61,46 | 5,24 | 22,91 |
CS | Aktier | 409,174 mio. | — | CS China Southern | 0,20 | Sundhedsvæsen | CSI Innovative Pharmaceutical Industrial Index - CNY - Benchmark TR Gross | 12.3.2021 | 0,64 | 3,14 | 28,61 |